Theophylline toxicity: Difference between revisions
No edit summary |
|||
Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Still used in patients with debilitating brochospastic disease | |||
*Studied for treatment of [[Acute Mountain Sickness]] and [[Contrast-Induced Nephropathy]] | |||
*PO in elixir, extended release, or controlled release forms but absorption erratic | |||
*IV as aminophylline | |||
*Adenosine antagonism, Increase catecholamines, and Phosphodiesterase inhibition | |||
==Clinical Features== | ==Clinical Features== | ||
*Neurologic | |||
**Tremor | |||
**Agitation | |||
**[[Seizure]] | |||
*Cardiovascular | |||
**[[Sinus Tachycardia]] | |||
**Atrial/Ventricular [[arrhythmias]] | |||
**[[Hypotension]] | |||
*Metabolic | |||
**[[Hypokalemia]] | |||
**[[Metabolic Acidosis]] | |||
**[[Hyperthermia]] | |||
**[[Rhabdomyolysis]] | |||
**[[Hyperglycemia]] | |||
*GI | |||
**[[Nausea/Vomiting]] | |||
==Workup== | ==Workup== | ||
*[[ECG]] | |||
*Chem | |||
*CK | |||
*Theophylline level | |||
==Management== | ==Management== | ||
*GI decontamination ([[Multidose Activated Charcoal]], [[Whole Bowel Irrigation]]) | |||
**Considered in life-threatening overdose | |||
***contraindications: unsecured airway, [[nausea]], [[vomiting]], ileus, [[Bowel Obstruction]], or need for emergent endoscopy | |||
*[[Seizures]] | |||
**[[Lorazepam]] (Ativan) 1st line | |||
**Phenobarbital if [[lorazepam]] ineffective | |||
**Phenytoin (Dilantin) contraindicated as increases seizure in animal studies | |||
*Cardiovascular | |||
**[[IV Fluids]] for [[hypotension]] | |||
**Beta blockers for [[tachyarrhymias]] | |||
***Controversial, involve a toxicologist | |||
*Dialysis | |||
**Indicated in [[seizures]], severe [[arrhythmias]] | |||
**Theophylline level >90mcg/ml in acute ingestion | |||
**Theophylline level >40mcg/ml in chronic ingestion | |||
*Supportive care | |||
**Cardiac monitoring | |||
**Ondansetron (Zofran) for antiemetic | |||
**EEG for sedated and paralyzed patients | |||
==Disposition== | ==Disposition== | ||
*Immediate release | |||
**Home after 6 hours if | |||
***nontoxic | |||
***asymptomatic | |||
***and, normal vital sign | |||
*Sustained release | |||
**Home after 12 hours if | |||
***nontoxic | |||
***asymptomatic | |||
***and, normal vital sign | |||
==References== | ==References== | ||
[[Category:Toxicology]] | [[Category:Toxicology]] |
Revision as of 22:14, 20 September 2016
Background
- Still used in patients with debilitating brochospastic disease
- Studied for treatment of Acute Mountain Sickness and Contrast-Induced Nephropathy
- PO in elixir, extended release, or controlled release forms but absorption erratic
- IV as aminophylline
- Adenosine antagonism, Increase catecholamines, and Phosphodiesterase inhibition
Clinical Features
- Neurologic
- Tremor
- Agitation
- Seizure
- Cardiovascular
- Sinus Tachycardia
- Atrial/Ventricular arrhythmias
- Hypotension
- Metabolic
- GI
Workup
- ECG
- Chem
- CK
- Theophylline level
Management
- GI decontamination (Multidose Activated Charcoal, Whole Bowel Irrigation)
- Considered in life-threatening overdose
- contraindications: unsecured airway, nausea, vomiting, ileus, Bowel Obstruction, or need for emergent endoscopy
- Considered in life-threatening overdose
- Seizures
- Cardiovascular
- IV Fluids for hypotension
- Beta blockers for tachyarrhymias
- Controversial, involve a toxicologist
- Dialysis
- Indicated in seizures, severe arrhythmias
- Theophylline level >90mcg/ml in acute ingestion
- Theophylline level >40mcg/ml in chronic ingestion
- Supportive care
- Cardiac monitoring
- Ondansetron (Zofran) for antiemetic
- EEG for sedated and paralyzed patients
Disposition
- Immediate release
- Home after 6 hours if
- nontoxic
- asymptomatic
- and, normal vital sign
- Home after 6 hours if
- Sustained release
- Home after 12 hours if
- nontoxic
- asymptomatic
- and, normal vital sign
- Home after 12 hours if